Actelion: Delivering well on schedule

BUY-Top Picks, Fair Value CHF156 vs. CHF154 (+20%)
News published on October Wednesday 21, 2015
Share on

A new FV of CHF156 derives from revised assumptions with Opsumit as it should take fewer years than we anticipated to reach peak sales. The investment case is very much valid post Q3 numbers.

For more information, please contact 

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities